Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021

Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021

<strong>Foundation</strong>: SARS-CoV-2 infection is the most important emerging disease of this century. In this context, the Cuban Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) created therapeutic alternatives to combat COVID-19, including the use of Jusvinza, which...

Full description

Bibliographic Details
Main Authors: Sandra Caridad Laurencio Vallina, Martha María Arias Carbonell, Leonardo Ramos Hechavarría, Dayami Lescay Balanquet, Roger Pina Núñez
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2024-02-01
Series:Medisur
Subjects:
infecciones por coronavirus
factores inmunitarios
morbilidad
mortalidad
resultado del tratamiento
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/45089

Internet

http://medisur.sld.cu/index.php/medisur/article/view/45089

Similar Items